Bruce Kerwin, Ph.D.
SVP, Head of Process and Product Development
Kerwin joins Umoja as a recognized industry expert in formulation and drug development with over 25 years of experience leading project teams through multiple stages of development from pre-IND to commercialization. Prior to Umoja, he was an original member of Just Biotherapeutics founding the biophysics and drug product design department, where he led the molecular optimization programs for anti-HIV broadly neutralizing antibodies for both the Bill and Melinda Gates Foundation and the National Institute of Allergy and Infectious Disease. In prior roles at Amgen, he led numerous project teams developing novel solutions to formulation problems such as high viscosity, high concentration and drug delivery and contributed to numerous programs that successfully brought drug candidates through development and commercialization. He has over 50 research publications, is an inventor on multiple patents, and is an Adjunct Professor in the School of Pharmaceutical Chemistry at the University of Kansas. He received his Ph.D. in Biochemistry from the University of California at Davis.